FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pinuccia Valagussa

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Vittorio Montefusco; Alberto Mussetti; Massimo Offidani; Francesca Patriarca; Ilaria Scortechini; Alessandra Sperotto; Francesco Spina; Pinuccia Valagussa; Benedetto Bruno; Anna Dodero; Renato Fanin; Mauro Montanari; Paolo Corradini
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation.
Milvia Zambetti; Mauro Mansutti; Paolo Morandi; Lorenzo Pavesi; Vladimir Semiglazov; Pinuccia Valagussa; Claudio Zamagni; Mario Bari; Eva Ciruelos; Elena De Benedictis; Christian Dittrich; Fernando Gaion; Patricia Gomez; Ana Lluch; Gianni Luca
Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II).
Alessandro Gronchi; Alessandra Longhi; Antonio Lopez-Pousa; Lidia Mariani; Javier Martin; Mario Mercuri; Rosalba Miceli; Paolo Giovanni Casali; Alessandro Comandone; Antonino De Paoli; Angelo Paolo Dei Tos; Sergio Frustaci; Andres Poveda; Vittorio Quagliuolo; Silvia Stacchiotti; Pinuccia Valagussa; Paolo Verderio; Piero Picci
Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pinuccia Valagussa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Vittorio Montefusco; Alberto Mussetti; Massimo Offidani; Francesca Patriarca; Ilaria Scortechini; Alessandra Sperotto; Francesco Spina; Pinuccia Valagussa; Benedetto Bruno; Anna Dodero; Renato Fanin; Mauro Montanari; Paolo Corradini
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(3):424-8.
2012: Milvia Zambetti; Mauro Mansutti; Paolo Morandi; Lorenzo Pavesi; Vladimir Semiglazov; Pinuccia Valagussa; Claudio Zamagni; Mario Bari; Eva Ciruelos; Elena De Benedictis; Christian Dittrich; Fernando Gaion; Patricia Gomez; Ana Lluch; Gianni Luca
Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II).
Breast cancer research and treatment 2012;132(3):843-51.
2012: Alessandro Gronchi; Alessandra Longhi; Antonio Lopez-Pousa; Lidia Mariani; Javier Martin; Mario Mercuri; Rosalba Miceli; Paolo Giovanni Casali; Alessandro Comandone; Antonino De Paoli; Angelo Paolo Dei Tos; Sergio Frustaci; Andres Poveda; Vittorio Quagliuolo; Silvia Stacchiotti; Pinuccia Valagussa; Paolo Verderio; Piero Picci
Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(8):850-6.
2011: Simonetta Viviani; Francesco Zaja; Pier Luigi Zinzani; Delia Rota Scalabrini; Gianni Bonadonna; Valeria Bonfante; Ercole Brusamolino; Andrea Gallamini; ALESSANDRO MASSIMO GIANNI; Manuel Gotti; Alessandro Levis; Anna Marina Liberati; Enrico M Pogliani; Patrizia Pregno; Alessandro Pulsoni; Alessandro Rambaldi; Andrea Rossi; Giorgina Specchia; Pinuccia Valagussa; Umberto Vitolo
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
The New England journal of medicine 2011;365(3):203-12.
2010: Simonetta Viviani; Massimo Di Nicola; Valeria Bonfante; Antonio Di Stasi; Carmelo Carlo-Stella; Paola Matteucci; Michele Magni; liliana devizzi; Pinuccia Valagussa; ALESSANDRO MASSIMO GIANNI
Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience.
Leukemia & lymphoma 2010;51(7):1251-9.
2010: Romano Demicheli; Elia Biganzoli; Ilaria Ardoino; Patrizia Boracchi; Danila Coradini; Marco Greco; Angela Moliterni; Milvia Zambetti; Pinuccia Valagussa; Isaac D Gukas; Gianni Bonadonna
Recurrence and mortality dynamics for breast cancer patients undergoing mastectomy according to estrogen receptor status: different mortality but similar recurrence.
Cancer science 2010;101(3):826-30.
2010: Luca Gianni; Wolfgang Eiermann; Vladimir Semiglazov; Alexey Manikhas; Ana Lluch; Sergey Tjulandin; Milvia Zambetti; Federico Vazquez; Mikhail Byakhow; Mikhail Lichinitser; Miguel Angel Climent; Eva Ciruelos; Belén Ojeda; Mauro Mansutti; Alla Bozhok; Roberta Baronio; Andrea Feyereislova; Claire Barton; Pinuccia Valagussa; Jose Baselga
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.
Lancet 2010;375(9712):377-84.
2009: Luca Gianni; José Baselga; Wolfgang Eiermann; Vincente Guillem Porta; Vladimir Semiglazov; Ana Lluch; Milvia Zambetti; Dolores Sabadell; Günther Raab; Antonio Llombart Cussac; Alla Bozhok; Angel Martinez-Agulló; Marco Greco; Mikhail Byakhov; Juan Josè Lopez Lopez; Mauro Mansutti; Pinuccia Valagussa; Gianni Bonadonna
Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(15):2474-81.
2009: Luca Gianni; Pinuccia Valagussa
Anthracyclines and early breast cancer: the end of an era?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(8):1155-7.
2009: Pinuccia Valagussa
History of adjuvant therapy.
Cancer treatment and research 2009;151():3-12.
2008: Patrizia Casalini; Maria Luisa Carcangiu; Raija Tammi; Paivi Auvinen; Veli-Matti Kosma; Pinuccia Valagussa; Marco Greco; Andrea Balsari; Sylvie Ménard; Elda Tagliabue
Two distinct local relapse subtypes in invasive breast cancer: effect on their prognostic impact.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(1):25-31.
2007: Romano Demicheli; William J M Hrushesky; Michael Retsky; Gianni Bonadonna; Pinuccia Valagussa
Comment to "Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and intact primary tumor" by G V Babiera, R Rao, L Feng, F Meric-Bernstam, H M Kuerer, S E Singletary, K K Hunt, M I Ross, K M Gwyn, B W Feig, F C Ames, G N Horthobagyi. Ann Surg Oncol 2006;13:776-782.
Annals of surgical oncology 2007;14(4):1519-20.
2006: Gabriella Mariani; Fausto Petrelli; Milvia Zambetti; Angela Moliterni; Angelica Fasolo; Alfonso Marchiano; Pinuccia Valagussa; Luca Gianni
Capecitabine/Cyclophosphamide/Methotrexate for patients with metastatic breast cancer: a dose-finding, feasibility, and efficacy study.
Clinical breast cancer 2006;7(4):321-5.
2006: Paolo Corradini; Corrado Tarella; Francesco Zallio; Anna Dodero; Manuela Zanni; Pinuccia Valagussa; ALESSANDRO MASSIMO GIANNI; Alessandro Rambaldi; T Barbui; Sergio Cortelazzo
Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation.
Leukemia 2006;20(9):1533-8.
2006: Romano Demicheli; Gianni Bonadonna; Marco Greco; William J M Hrushesky; Angela Moliterni; Michael Retsky; Pinuccia Valagussa; Milvia Zambetti
Comment to Anderson WF, Jatoi I, Devesa SS: distinct breast cancer incidence and prognostic patterns in the NCI'S SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90:127-137, 2005.
Breast cancer research and treatment 2006;97(3):341-3.
2006: Manfred Kaufmann; Gabriel N Hortobagyi; Aron Goldhirsch; Suzy Scholl; Andreas Makris; Pinuccia Valagussa; Jens-Uwe Blohmer; Wolfgang Eiermann; Raimund Jackesz; Walter Jonat; Annette Lebeau; Sibylle Loibl; William Miller; Sigfried Seeber; Vladimir Semiglazov; Roy Smith; Rainer Souchon; Vered Stearns; Michael Untch; Gunter von Minckwitz
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1940-9.
2005: Luca Gianni; José Baselga; Wolfgang Eiermann; Vicente Guillem Porta; Vladimir Semiglazov; Ana Lluch; Milvia Zambetti; Dolores Sabadell; Günther Raab; Antonio Llombart-Cussac; Alla Bozhok; Angel Martinez-Agulló; Marco Greco; Mikhail Byakhov; Juan Josè Lopez Lopez; Mauro Mansutti; Pinuccia Valagussa; Gianni Bonadonna
Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8715-21.
2005: Luca Gianni; Milvia Zambetti; Kim Clark; Joffre Baker; Maureen Cronin; Jenny Wu; Gabriella Mariani; Jaime Rodriguez; Marialuisa Carcangiu; Drew Watson; Pinuccia Valagussa; Roman Rouzier; W Fraser Symmans; Jeffrey S Ross; Gabriel N Hortobagyi; Lajos Pusztai; Steven Shak
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(29):7265-77.
2005: Paolo Corradini; Francesco Zallio; J Mariotti; Lucia Farina; Marco Bregni; Pinuccia Valagussa; Fabio Ciceri; Andrea Bacigalupo; Anna Dodero; Moira Lucesole; Francesca Patriarca; Alessandro Rambaldi; Rosanna Scimè; Anna Locasciulli; Giuseppe Bandini; ALESSANDRO MASSIMO GIANNI; Corrado Tarella; Attilio Olivieri
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6690-8.
2005: Romano Demicheli; Gianni Bonadonna; Pinuccia Valagussa; Michael Retsky; William J M Hrushesky; Michael Baum
Comment to Jatoi et al. report.
Breast cancer research and treatment 2005;93(1):1-2.
2005: Romano Demicheli; Rosalba Miceli; Angela Moliterni; Milvia Zambetti; William J M Hrushesky; Michael Retsky; Pinuccia Valagussa; Gianni Bonadonna
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(9):1449-57.
2005: Gianni Bonadonna; Simonetta Viviani; Valeria Bonfante; ALESSANDRO MASSIMO GIANNI; Pinuccia Valagussa
Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
European journal of cancer (Oxford, England : 1990) 2005;41(7):998-1006.
2005: Gianni Bonadonna; Angela Moliterni; Milvia Zambetti; Maria Grazia Daidone; Silvana Pilotti; Luca Gianni; Pinuccia Valagussa
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study.
BMJ (Clinical research ed.) 2005;330(7485):217.
2004: Monica Terenziani; Filippo Spreafico; Paola Collini; Luigi Piva; D Perotti; Marta Podda; Lorenza Gandola; maura massimino; Stefano Cereda; Graziella Cefalo; Roberto Luksch; Michela Casanova; Andrea Ferrari; Daniela Polastri; Pinuccia Valagussa; Franca Fossati-Bellani
Adult Wilms' tumor: A monoinstitutional experience and a review of the literature.
Cancer 2004;101(2):289-93.
2004: Gianni Bonadonna; Valeria Bonfante; Simonetta Viviani; Anna Di Russo; Fabrizio Villani; Pinuccia Valagussa
ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2835-41.
2004: Gianni Bonadonna; Milvia Zambetti; Angela Moliterni; Luca Gianni; Pinuccia Valagussa
Clinical relevance of different sequencing of doxorubicin and cyclophosphamide, methotrexate, and Fluorouracil in operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1614-20.
2004: maura massimino; Lorenza Gandola; Felice Giangaspero; alessandro sandri; Pinuccia Valagussa; Giorgio Perilongo; Maria Luisa Garrè; Umberto Ricardi; Marco Forni; Lorenzo Genitori; Giovanni Scarzello; Filippo Spreafico; Salvina Barra; Maurizio Mascarin; Bianca Pollo; Marina Gardiman; Armando Cama; Pierina Navarria; Maurizio Brisigotti; Paola Collini; Rita Balter; Paola Fidani; Maurizio Stefanelli; Roberta Burnelli; Paolo Potepan; Marta Podda; Guido Sotti; Enrico Madon
Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study.
International journal of radiation oncology, biology, physics 2004;58(5):1336-45.
2004: Romano Demicheli; Gianni Bonadonna; William J M Hrushesky; Michael Retsky; Pinuccia Valagussa
Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour.
Breast cancer research : BCR 2004;6(6):R689-96.
2004: Michael Retsky; Gianni Bonadonna; Romano Demicheli; Judah Folkman; William J M Hrushesky; Pinuccia Valagussa
Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients.
Breast cancer research : BCR 2004;6(4):R372-4.
2004: Romano Demicheli; Gianni Bonadonna; William J M Hrushesky; Michael Retsky; Pinuccia Valagussa
Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screening.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):102-7.
2003: Paolo Corradini; Michele Cavo; Henk M Lokhorst; giovanni martinelli; Carolina Terragna; Ignazio Majolino; Pinuccia Valagussa; Mario Boccadoro; Diana Samson; Andrea Bacigalupo; Nigel Russell; Vittorio Montefusco; Claudia Voena; Gösta Gahrton
Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma.
Blood 2003;102(5):1927-9.
2003: Manuela Campiglio; Giulia Somenzi; Clelia Olgiati; Giovanni Beretta; Andrea Balsari; Nadia Zaffaroni; Pinuccia Valagussa; Sylvie Ménard
Role of proliferation in HER2 status predicted response to doxorubicin.
International journal of cancer. Journal international du cancer 2003;105(4):568-73.
2003: John W Gamel; Gianni Bonadonna; Pinuccia Valagussa; Michael J Edwards
Refined measurement of outcome for adjuvant breast carcinoma therapy.
Cancer 2003;97(5):1139-46.
2003: Lisa Licitra; Laura D Locati; Raffaele Cavina; Isabella Garassino; Franco Mattavelli; Natalia Pizzi; Pasquale Quattrone; Pinuccia Valagussa; Luca Gianni; Gianni Bonadonna; Carlo L Solero; Giulio Cantu
Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(3):367-72.
2003: Angela Moliterni; Sylvie Ménard; Pinuccia Valagussa; Elia Biganzoli; Patrizia Boracchi; Andrea Balsari; Patrizia Casalini; Gorana Tomasic; Ettore Marubini; Silvana Pilotti; Gianni Bonadonna
HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(3):458-62.
2003: Lisa Licitra; Cesare Grandi; Marco Guzzo; Luigi Mariani; Salvatore Lo Vullo; Francesca Valvo; Pasquale Quattrone; Pinuccia Valagussa; Gianni Bonadonna; Roberto Molinari; Giulio Cantù
Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):327-33.
2003: Pinuccia Valagussa; Gianni Bonadonna
Breast cancer.
Cancer chemotherapy and biological response modifiers 2003;21():585-608.
2002: Romano Demicheli; Pinuccia Valagussa; Gianni Bonadonna
Double-peaked time distribution of mortality for breast cancer patients undergoing mastectomy.
Breast cancer research and treatment 2002;75(2):127-34.
2002: Gianni Bonadonna; Milvia Zambetti; Cesare Bumma; Michela Donadio; A Bolognesi; Gioacchino Robustelli Della Cuna; G Ambrosini; Giorgio Lelli; Mauro Mansutti; P Verderio; Pinuccia Valagussa
Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(7):1049-58.
2002: Paolo Bidoli; Emilio Bajetta; Simonetta Chiara Stani; Candis Daniela De; Armando Santoro; Maurizio Valente; Roberto Zucali; Pinuccia Valagussa; Gianni Ravasi; Gianni Bonadonna
Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus.
Cancer 2002;94(2):352-61.
2002: Pinuccia Valagussa; Gianni Bonadonna
Breast cancer.
Cancer chemotherapy and biological response modifiers 2002;20():493-517.
2001: G Mariani; P Tagliabue; P Zucchinelli; C Brambilla; Romano Demicheli; E Villa; A Marchianò; Pinuccia Valagussa; Gianni Bonadonna; Luca Gianni
Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer.
Breast cancer research and treatment 2001;70(3):163-9.
2001: Romano Demicheli; Pinuccia Valagussa; Gianni Bonadonna
Does surgery modify growth kinetics of breast cancer micrometastases?
British journal of cancer 2001;85(4):490-2.
2001: Valeria Bonfante; Simonetta Viviani; liliana devizzi; Anna Di Russo; Massimo Di Nicola; Michele Magni; Paola Matteucci; Salvatore Grisanti; Pinuccia Valagussa; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease.
European journal of haematology. Supplementum 2001;64():51-5.
2001: Giacomo Grasselli; Lucia Viganò; Giuseppe Capri; Alberta Locatelli; E Tarenzi; C Spreafico; A Bertuzzi; A Giani; C Materazzo; Sara Cresta; Antonella Perotti; Pinuccia Valagussa; Luca Gianni
Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2222-31.
2001: Luca Gianni; Pinuccia Valagussa; Milvia Zambetti; Angela Moliterni; Giuseppe Capri; Gianni Bonadonna
Adjuvant and neoadjuvant treatment of breast cancer.
Seminars in oncology 2001;28(1):13-29.
2001: Sylvie Ménard; Pinuccia Valagussa; Silvana Pilotti; Luca Gianni; Elia Biganzoli; Patrizia Boracchi; Gorana Tomasic; Patrizia Casalini; Ettore Marubini; MI Colnaghi; Natale Cascinelli; Gianni Bonadonna
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):329-35.
2001: Pinuccia Valagussa; Gianni Bonadonna
Breast cancer.
Cancer chemotherapy and biological response modifiers 2001;19():597-628.
2001: Milvia Zambetti; Angela Moliterni; C Materazzo; M Stefanelli; sonia cipriani; Pinuccia Valagussa; Gianni Bonadonna; Luca Gianni
Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):37-43.
2000: Marco Greco; M Gennaro; Pinuccia Valagussa; Roberto Agresti; C Ferraris; B Ferrari; C Urban; Luca Gianni
Impact of nodal status on indication for adjuvant treatment in clinically node negative breast cancer. Istituto Nazionale per lo Studio e las Cura dei Tumori.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(9):1137-40.
2000: R Silvestrini; A Luisi; Milvia Zambetti; sonia cipriani; Pinuccia Valagussa; Gianni Bonadonna; Maria Grazia Daidone
Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer.
International journal of cancer. Journal international du cancer 2000;87(3):405-11.
2000: C Tondini; Monica Balzarotti; I Rampinelli; Pinuccia Valagussa; M Luoni; Alberto De Paoli; Armando Santoro; Gianni Bonadonna
Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(2):231-3.
2000: Simonetta Viviani; P Notti; Valeria Bonfante; P Verderio; Pinuccia Valagussa; Gianni Bonadonna
Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experience.
Medical oncology (Northwood, London, England) 2000;17(1):59-63.
1999: Umberto Veronesi; Ettore Marubini; Luigi Mariani; Pinuccia Valagussa; Roberto Zucali
The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial.
European journal of cancer (Oxford, England : 1990) 1999;35(9):1320-5.
1999: C Tondini; A J Ferreri; L Siracusano; Pinuccia Valagussa; Roberto Giardini; I Rampinelli; Gianni Bonadonna
Diffuse large-cell lymphoma of the testis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2854-8.
1999: Simonetta Viviani; Valeria Bonfante; Armando Santoro; M Zanini; liliana devizzi; Anna Di Russo; F Soncini; Fabrizio Villani; G Ragni; Pinuccia Valagussa; Gianni Bonadonna
Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
The cancer journal from Scientific American 1999;5(5):275-82.
1999: Milvia Zambetti; Saro Oriana; Pasquale Quattrone; P Verderio; Monica Terenziani; Roberto Zucali; Pinuccia Valagussa; Gianni Bonadonna
Combined sequential approach in locally advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(3):305-10.
1999: Romano Demicheli; Rosalba Miceli; C Brambilla; L Ferrari; Angela Moliterni; Milvia Zambetti; Pinuccia Valagussa; Gianni Bonadonna
Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'.
Breast cancer research and treatment 1999;53(3):209-15.
1998: Valeria Bonfante; Simonetta Viviani; Armando Santoro; liliana devizzi; Anna Di Russo; M Zanini; F Soncini; H Soto Parra; Pinuccia Valagussa; Gianni Bonadonna
Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's disease.
British journal of haematology 1998;103(2):533-5.
1998: Michael J Edwards; G Bonadonna; Pinuccia Valagussa; John W Gamel
End points in the analysis of breast cancer survival: relapse versus death from tumor.
Surgery 1998;124(2):197-202.
1998: Simonetta Viviani; E Camerini; Valeria Bonfante; Armando Santoro; Monica Balzarotti; Monica Fornier; liliana devizzi; P Verderio; Pinuccia Valagussa; Gianni Bonadonna
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
British journal of cancer 1998;77(6):992-7.
1998: Luca Gianni; Giuseppe Capri; Pinuccia Valagussa; Gianni Bonadonna
Putting taxanes to work in operable breast cancer: a search for selective indications from empirical studies.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;152():314-22.
1998: Gianni Bonadonna; Pinuccia Valagussa; C Brambilla; L Ferrari; Angela Moliterni; Monica Terenziani; Milvia Zambetti
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):93-100.
1997: Angela Moliterni; E Tarenzi; Giuseppe Capri; Monica Terenziani; A Bertuzzi; Giacomo Grasselli; Roberto Agresti; P Piotti; Marco Greco; Bruno Salvadori; Silvana Pilotti; F Lombardi; Pinuccia Valagussa; Gianni Bonadonna; Luca Gianni
Pilot study of primary chemotherapy with doxorubicin plus paclitaxel in women with locally advanced or operable breast cancer.
Seminars in oncology 1997;24(5 Suppl 17):S17-10-S17-14.
1997: Michael Retsky; Romano Demicheli; Douglas Swartzendruber; P D Bame; R H Wardwell; Gianni Bonadonna; J F Speer; Pinuccia Valagussa
Computer simulation of a breast cancer metastasis model.
Breast cancer research and treatment 1997;45(2):193-202.
1997: ALESSANDRO MASSIMO GIANNI; Salvatore Siena; Marco Bregni; M Di Nicola; S Orefice; F Cusumano; Bruno Salvadori; Alberto Luini; Marco Greco; Roberto Zucali; F Rilke; Milvia Zambetti; Pinuccia Valagussa; Gianni Bonadonna
Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2312-21.
1997: ALESSANDRO MASSIMO GIANNI; Marco Bregni; Salvatore Siena; C Brambilla; Massimo Di Nicola; F Lombardi; Lorenza Gandola; Corrado Tarella; Alessandro Pileri; Fernando Ravagnani; Pinuccia Valagussa; Gianni Bonadonna
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma.
The New England journal of medicine 1997;336(18):1290-7.
1997: Valeria Bonfante; Armando Santoro; Simonetta Viviani; liliana devizzi; Monica Balzarotti; F Soncini; M Zanini; Pinuccia Valagussa; Gianni Bonadonna
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):528-34.
1997: liliana devizzi; Lorenzo Maffioli; Valeria Bonfante; Simonetta Viviani; L Balzarini; Massimo Gasparini; Pinuccia Valagussa; Emilio Bombardieri; Armando Santoro; Gianni Bonadonna
Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 1():53-6.
1996: Gianni Bonadonna; Pinuccia Valagussa
Primary chemotherapy in operable breast cancer.
Seminars in oncology 1996;23(4):464-74.
1996: Milvia Zambetti; Pinuccia Valagussa; Gianni Bonadonna
Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):481-5.
1996: Simonetta Viviani; Gianni Bonadonna; Armando Santoro; Valeria Bonfante; M Zanini; liliana devizzi; F Soncini; Pinuccia Valagussa
Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1421-30.
1996: Milvia Zambetti; Monica Terenziani; Cesare Bartoli; Pinuccia Valagussa; P Piotti; C Ferranti; Gianni Bonadonna
Intermediate doses of cyclophosphamide alone or following adriamycin in advanced breast cancer. A pilot study.
American journal of clinical oncology 1996;19(1):82-6.
1996: Romano Demicheli; A Abbattista; Rosalba Miceli; Pinuccia Valagussa; Gianni Bonadonna
Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy.
Breast cancer research and treatment 1996;41(2):177-85.
1996: Pinuccia Valagussa; D De Candis; G Antonelli; Gianni Bonadonna
VIII. Women's health perception and breast cancer: issues of fertility, hormone substitution, and cancer prevention.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1996;140():277-83.
1995: Gianni Bonadonna; Pinuccia Valagussa; Angela Moliterni; Milvia Zambetti; C Brambilla
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up.
The New England journal of medicine 1995;332(14):901-6.
1995: Armando Santoro; H S Parra; P Bidoli; M Angelidou; I Cataldo; P Salvini; Pinuccia Valagussa; F Milani; Gianni Ravasi; Gianni Bonadonna
A summary of the Milan experience with multimodality therapies in patients with small cell lung cancer: attempts to improve long-term outcome.
Seminars in oncology 1995;22(1 Suppl 2):9-14.
1994: Pinuccia Valagussa; Angela Moliterni; Monica Terenziani; Milvia Zambetti; Gianni Bonadonna
Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(9):803-8.
1994: liliana devizzi; Armando Santoro; Valeria Bonfante; Simonetta Viviani; L Balzarini; Pinuccia Valagussa; Gianni Bonadonna
Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(9):817-20.
1994: Pinuccia Valagussa; Milvia Zambetti; S Biasi; Angela Moliterni; Roberto Zucali; Gianni Bonadonna
Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):209-16.
1994: Romano Demicheli; Monica Terenziani; Pinuccia Valagussa; Angela Moliterni; Milvia Zambetti; Gianni Bonadonna
Local recurrences following mastectomy: support for the concept of tumor dormancy.
Journal of the National Cancer Institute 1994;86(1):45-8.
1993: C Tondini; Roberto Giardini; F Bozzetti; Pinuccia Valagussa; Armando Santoro; R Bertulli; Monica Balzarotti; Andrea Rocca; F Lombardi; A J Ferreri
Combined modality treatment for primary gastrointestinal non-Hodgkin's lymphoma: the Milan Cancer Institute experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(10):831-7.
1993: Gianni Bonadonna; Luca Gianni; Armando Santoro; Valeria Bonfante; P Bidoli; P Casali; R Demicheli; Pinuccia Valagussa
Drugs ten years later: epirubicin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(5):359-69.
1993: C Tondini; M Zanini; F Lombardi; C Bengala; Andrea Rocca; Roberto Giardini; R Buzzoni; Pinuccia Valagussa; Gianni Bonadonna
Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):720-5.
1993: Pinuccia Valagussa; Angela Moliterni; Milvia Zambetti; Gianni Bonadonna
Long-term sequelae from adjuvant chemotherapy.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;127():247-55.
1993: Gianni Bonadonna; U Veronesi; C Brambilla; L Ferrari; P Passoni; G F Coopmans de Yoldi; A Luini; Marco Greco; Pinuccia Valagussa
Primary chemotherapy for resectable breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;127():113-7.
1992: Pinuccia Valagussa; Armando Santoro; Gianni Bonadonna
Thyroid, pulmonary, and cardiac sequelae after treatment for Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():111-5.
1992: Valeria Bonfante; Armando Santoro; Simonetta Viviani; Pinuccia Valagussa; Gianni Bonadonna
ABVD in the treatment of Hodgkin's disease.
Seminars in oncology 1992;19(2 Suppl 5):38-44; discussion 44-5.
1992: Valeria Bonfante; Armando Santoro; Simonetta Viviani; Roberto Zucali; liliana devizzi; M Zanini; J D Tesoro Tess; Pinuccia Valagussa; A Banfi; Gianni Bonadonna
Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP.
European journal of cancer (Oxford, England : 1990) 1992;29A(1):24-9.
1991: R Buzzoni; Gianni Bonadonna; Pinuccia Valagussa; Milvia Zambetti
Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(12):2134-40.
1991: Gianni Bonadonna; Pinuccia Valagussa; C Brambilla; Angela Moliterni; Milvia Zambetti; Leonardo Ferrari
Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy.
Seminars in oncology 1991;18(6):515-24.
1991: ALESSANDRO MASSIMO GIANNI; Salvatore Siena; Marco Bregni; F Lombardi; L Gandola; Pinuccia Valagussa; Gianni Bonadonna
Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(9):645-53.
1991: Angela Moliterni; Gianni Bonadonna; Pinuccia Valagussa; Leonardo Ferrari; Milvia Zambetti
Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(7):1124-30.
1991: Simonetta Viviani; Gianni Bonadonna; Armando Santoro; M Zanini; Roberto Zucali; E Negretti; Pinuccia Valagussa
Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():55-62.
1991: Simonetta Viviani; Guido Ragni; Armando Santoro; L Perotti; E Caccamo; E Negretti; Pinuccia Valagussa; Gianni Bonadonna
Testicular dysfunction in Hodgkin's disease before and after treatment.
European journal of cancer (Oxford, England : 1990) 1991;27(11):1389-92.
1990: R Silvestrini; Maria Grazia Daidone; Pinuccia Valagussa; G Di Fronzo; G Mezzanotte; Luigi Mariani; Gianni Bonadonna
3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(8):1321-6.
1990: Gianni Bonadonna; Pinuccia Valagussa
Influence of clinical trials on current treatment strategy for Hodgkin's disease.
International journal of radiation oncology, biology, physics 1990;19(1):209-18.
1990: Pinuccia Valagussa; Milvia Zambetti; Gianni Bonadonna; Roberto Zucali; G Mezzanotte; U Veronesi
Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy.
Breast cancer research and treatment 1990;15(3):137-47.
1990: Simonetta Viviani; Armando Santoro; E Negretti; Valeria Bonfante; Pinuccia Valagussa; Gianni Bonadonna
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(2):123-7.
1989: R Silvestrini; Maria Grazia Daidone; Pinuccia Valagussa; G Di Fronzo; G Mezzanotte; Gianni Bonadonna
Cell kinetics as a prognostic indicator in node-negative breast cancer.
European journal of cancer & clinical oncology 1989;25(8):1165-71.
1989: Pinuccia Valagussa; C Brambilla; Milvia Zambetti; Gianni Bonadonna
Salvage treatments in relapsing resectable breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():69-76.
1989: Gianni Bonadonna; Pinuccia Valagussa; Milvia Zambetti; C Brambilla
The Milan experience with adjuvant chemotherapy in premenopausal breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():113-7.
1989: Gianni Bonadonna; Milvia Zambetti; Pinuccia Valagussa
Adjuvant chemotherapy for node-negative breast cancer patients.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():175-9.
1989: Gianni Bonadonna; Pinuccia Valagussa; A Santoro; Simonetta Viviani; Valeria Bonfante; A Banfi
Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVD.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():169-74.
1988: C Verusio; Emilio Bajetta; L Ferrari; C Bartoli; Pinuccia Valagussa; Gianni Bonadonna
Cyclophosphamide, adriamycin, and cis-platinum (CAP) in metastatic and locally advanced breast cancer.
American journal of clinical oncology 1988;11(4):435-9.
1988: Emilio Bajetta; Pinuccia Valagussa; Gianni Bonadonna; A Lattuada; R Buzzoni; F Rilke; A Banfi
Combined modality treatment for stage I-II non-Hodgkin's lymphomas: CVP versus BACOP chemotherapy.
International journal of radiation oncology, biology, physics 1988;15(1):3-12.
1988: Emilio Bajetta; R Buzzoni; Pinuccia Valagussa; Gianni Bonadonna
Mitoxantrone: an active agent in refractory non-Hodgkin's lymphomas.
American journal of clinical oncology 1988;11(2):100-3.
1987: Leonardo Ferrari; Emilio Bajetta; Luca Gianni; C Verusio; C Bartoli; Pinuccia Valagussa; Gianni Bonadonna
Four-drug sequential regimen in advanced breast cancer.
Breast cancer research and treatment 1987;10(2):151-7.
1987: R B Weiss; Pinuccia Valagussa; Angela Moliterni; Milvia Zambetti; R Buzzoni; Gianni Bonadonna
Adjuvant chemotherapy after conservative surgery plus irradiation versus modified radical mastectomy. Analysis of drug dosing and toxicity.
The American journal of medicine 1987;83(3):455-63.
1986: Pinuccia Valagussa; A Santoro; F Fossati-Bellani; A Banfi; Gianni Bonadonna
Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(6):830-7.
1984: Gianni Bonadonna; P Bignami; R Buzzoni; Angela Moliterni; Pinuccia Valagussa; U Veronesi
New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1984;91():210-3.
1982: Pinuccia Valagussa; A Santoro; F Fossati Bellani; F Franchi; A Banfi; Gianni Bonadonna
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.
Blood 1982;59(3):488-94.
1981: Gianni Bonadonna; A Rossi; G Tancini; E Bajetta; S Marchini; C Brambilla; J D Tesoro Tess; Pinuccia Valagussa; A Banfi; U Veronesi
Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of Milan.
Cancer treatment reports 1981;65 Suppl 1():61-5.
1980: S Monfardini; A Banfi; Gianni Bonadonna; F Rilke; F Milani; Pinuccia Valagussa; A Lattuada
Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma.
International journal of radiation oncology, biology, physics 1980;6(2):125-34.
1980: Pinuccia Valagussa; A Santoro; R Kenda; F Fossati Bellani; F Franchi; A Banfi; F Rilke; Gianni Bonadonna
Second malignancies in Hodgkin's disease: a complication of certain forms of treatment.
British medical journal 1980;280(6209):216-9.